MYELOMA March 28, 2018 by Iqra Mumal, MSc ACCoRd Trial to Test Ninlaro Treatment for ASCT-Relapsed Multiple Myeloma A new Phase 3 clinical trial called ACCoRd is underway to investigate the benefits of adding Ninlaro (ixazomib) – a proteasome inhibitor – to…